Respiratory Tract Infections, Lower

Mr. Baker is prescribed azithromycin for a lower respiratory tract infection. The nurse tells Mr. Baker to take die drug on an empty stomach. Azithromycin is available in 250-mg tablets. The primary healdi care provider has ordered 500 mg on the first day, followed by 250 mg on days 2 to 5. How many tablets... 

Respiratory syncytial virus (RSV), a severe lower respiratory tract infection... 

Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection. Am J Manag Care 1997 3 1027-36. 

Bronchitis 3 times in the last 6 years, last episode 6 months ago Hospitalized with viral lower respiratory tract infections twice at ages 2 and 4... 

Chap. 68 - Lower Respiratory Tract Infections Universal Program Number 014-999-07-083-H04... 

Lower respiratory tract infections include infectious processes of the lungs and bronchi, pneumonia, bronchitis, bronchiolitis, and lung abscess. 

See Chap. Ill, Lower Respiratory Tract Infections, authored by Mark L. Glover and Michael D. Reed, for a more detailed discussion of this topic. 

Ceftizoxime is used for bacterial infections of the lower respiratory tract, infections of the urinary tract, infections of the bones, joints, skin, soft tissues, and abdominal infections. Synonyms of this drug are ceftix and eposerin. 

Respiratory - Upper respiratory tract infection, nasopharyngitis (14%) nasal cavity/sinus disease (6%) sinus headache, lower respiratory tract infection (4%) allergic rhinitis (more than 3%) rhinitis, laryngitis, tracheitis/bronchitis (1% to 3%). 

Miscellaneous Anxiety depression dizziness headache rash abdominal pain/discomfort gingival disorder infectious diarrhea nausea rectal pain/discomfort tooth disorder vomiting arthritis back pain myalgia lower extremity pain menstrual irregularity vaginitis influenza upper/lower respiratory tract infection fatigue otitis sleep disorder urinary tract infection. 

Otitis media,- sinusitis, lower respiratory tract infections, severe infections... 

Lower respiratory tract infections - Staphylococcus aureus (penicillinase-producing), Escherichia coli, Klebsiella sp., Enterobacter sp., Haemophilus influenzae, Haemophilus parainfluenzae, Acinetobactersp., Serratia marcescens. 

Lower respiratory tract infections - Lower respiratory tract infections, including... 

Lower respiratory tract infections Lower respiratory tract infections, including pneumonia and bronchitis caused by E. coli, K. pneumoniae, P. aeruginosa, Haemophilus influenzae, P. mirabilis, Enterobacter sp. and S. marcescens. Septicemia Septicemia caused by . coli, K. pneumoniae, P. aeruginosa, P. mirabilis, S. marcescens, and Enterobacter sp. 

Severe staphylococcal Infections - Severe staphylococcal infections (including methicillin-resistant staphylococci) in patients who cannot receive or who have failed to respond to penicillins and cephalosporins, or who have infections with resistant staphylococci. Infections may include endocarditis, bone infections, lower respiratory tract infections, septicemia, and skin and skin structure infections. 

Severe lower respiratory tract infections - Treatment of hospitalized infants and young children with severe lower respiratory tract infections caused by respiratory syncytial virus (RSV). 

Barreto, M. L., Santos, L. M., Assis, A. M., Araujo, M. P., Farenzena, G. G., Santos, P. A., and Fiaccone, R. L. (1994). Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil. Lancet 344, 228-231. 

A 16-year-old girl, a cystic fibrosis patient, is diagnosed with a ciprofloxacin-resistant Pseudomonas aeruginosa lower respiratory tract infection. 

Palivizumab is used to prevent serious lower respiratory tract infection due to RSV. It is used only in high-risk children who are younger than 24 months of age and have bronchopulmonary dysplasia or chronic lung disease that required treatment in the previous 6 months. It is also indicated for premature infants (less than 32 weeks gestation) until the age of 6 to 12 months. Palivizumab can reduce the incidence of RSV-related hospitalization by approximately half. The safety and efficacy of palivizumab in the treatment of RSV disease have not been established. 

Lower respiratory tract infection PO 500 mgq8h or 875 mg ql2h. 

Lower respiratory tract infections IV 400 mg ql2h for 7-14 days. PO 500mgql2hfor 7-14 days (750 mgql2h for 7-14 days for severe or complicated infections). Nosocomial pneumonia IV 400 mg q8h for 10-14 days. 

Unlabeled Uses Lower respiratory tract infections, febrile neutropenia, gynecologic and obstetric infections, sepsis... 

Skin and skin-structure, bone, joint, and lower respiratory tract infections septicemia endometriosis IV 3. Ig (3g ticarcillin) q4-6h. Maximum 18-24 g/day. 

Respiratory tract infection Bronchitis, pneumonia and other lower respiratory tract infections due to susceptible strains of Strep, pneumoniae, H. influenzae, K. pneumoniae and other organisms including Mycoplasma pneumoniae. Upper respiratory tract infections including sinusitis, otitis, mastoiditis. 

Lower respiratory tract infections e.g., pneumonia, acute bronchitis and acute exacerbations of chronic bronchitis. 

It is indicated in the treatment of lower respiratory tract infection e.g. bronchitis and pneumonia, upper respiratory tract infections e.g. pharyngitis and sinusitis, infections due to chlamydia, legionella and mycoplasma, skin and soft tissue infections and eradication of H. pylori with acid suppressants. 

It is indicated in upper and lower respiratory tract infections, skin infections, septicaemia, bone and joint infection including acute haematogenous osteomyelitis. 

Prevention of serious lower respiratory tract infection caused by respiratory syncytial virus in children less than 24 months of age with bronchopulmonary dysplasia or a history of prematurity (less than or equal to 35 weeks gestation)... 

---